{"id":3391,"date":"2024-01-29T17:49:46","date_gmt":"2024-01-29T12:19:46","guid":{"rendered":"https:\/\/eliteayurveda.com\/blog\/?p=3391"},"modified":"2024-12-03T11:14:52","modified_gmt":"2024-12-03T05:44:52","slug":"5-ayurvedic-tips-for-managing-your-autoimmune-condition","status":"publish","type":"post","link":"https:\/\/eliteayurveda.com\/blog\/5-ayurvedic-tips-for-managing-your-autoimmune-condition\/","title":{"rendered":"5 Ayurvedic Tips for Managing Your Autoimmune Condition"},"content":{"rendered":"\n<p><strong>Ayurvedic Tips for Managing Your Autoimmune Condition<\/strong><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><ul><li><a href=\"#understanding-autoimmune-conditions-in-ayurveda\">Understanding Autoimmune Conditions in Ayurveda<\/a><\/li><li><a href=\"#ayurvedic-tips-for-managing-autoimmune-conditions\">Ayurvedic Tips for Managing Autoimmune Conditions<\/a><ul><li><a href=\"#1-focus-on-digestive-health\">1. Focus on Digestive Health<\/a><\/li><li><a href=\"#2-detoxify-your-body\">2. Detoxify Your Body<\/a><\/li><li><a href=\"#3-balance-your-doshas\">3. Balance Your Doshas<\/a><\/li><li><a href=\"#4-strengthen-your-immunity\">4. Strengthen Your Immunity<\/a><\/li><li><a href=\"#5-manage-stress-effectively\">5. Manage Stress Effectively<\/a><\/li><li><a href=\"#6-incorporate-anti-inflammatory-practices\">6. Incorporate Anti-Inflammatory Practices<\/a><\/li><li><a href=\"#7-build-a-routine-dinacharya\">7. Build a Routine (Dinacharya)<\/a><\/li><li><a href=\"#8-stay-hydrated\">8. Stay Hydrated<\/a><\/li><li><a href=\"#9-regularly-monitor-your-symptoms\">9. Regularly Monitor Your Symptoms<\/a><\/li><\/ul><\/li><li><a href=\"#case-study-managing-autoimmune-disease-with-ayurveda\">Case Study: Managing Autoimmune Disease with Ayurveda<\/a><\/li><li><a href=\"#from-the-doctors-desk-key-takeaways\">From the Doctor\u2019s Desk: Key Takeaways<\/a><\/li><li><a href=\"#conclusion\">Conclusion<\/a><\/li><li><a href=\"#references\">References<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<p><strong>Introduction<\/strong><\/p>\n\n\n\n<p>Autoimmune conditions, where the immune system mistakenly attacks the body\u2019s healthy tissues, can lead to chronic inflammation and a range of symptoms affecting various organs and systems (Davidson &amp; Diamond, 2001). Conditions like rheumatoid arthritis, lupus, multiple sclerosis, and psoriasis are examples of autoimmune disorders that often require lifelong management (Rose &amp; Mackay, 2014).<\/p>\n\n\n\n<p>Ayurveda, the ancient Indian system of holistic healing, offers an effective and sustainable approach to managing autoimmune conditions (Sharma et al., 2007). By addressing the root causes\u2014such as doshic imbalances, toxin accumulation (<strong>Ama<\/strong>), and digestive issues\u2014Ayurveda aims to bring the body and mind into balance and provide lasting relief (Pole, 2013). At <strong>EliteAyurveda<\/strong>, we specialize in crafting personalized Ayurvedic treatment plans for autoimmune conditions.<\/p>\n\n\n\n<div class=\"wp-block-cover\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim\"><\/span><img loading=\"lazy\" decoding=\"async\" width=\"930\" height=\"524\" class=\"wp-block-cover__image-background wp-image-5083\" alt=\"Managing Your Autoimmune Condition\" src=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_.jpg\" data-object-fit=\"cover\" srcset=\"https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_.jpg 930w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_-300x169.jpg 300w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_-768x433.jpg 768w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_-696x392.jpg 696w, https:\/\/eliteayurveda.com\/blog\/wp-content\/uploads\/2024\/01\/doctor-talking-with-female-patient_-745x420.jpg 745w\" sizes=\"auto, (max-width: 930px) 100vw, 930px\" \/><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<p class=\"has-text-align-center has-large-font-size\">Managing Your Autoimmune Condition<\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"understanding-autoimmune-conditions-in-ayurveda\"><strong>Understanding Autoimmune Conditions in Ayurveda<\/strong><\/h3>\n\n\n\n<p>From an Ayurvedic perspective, autoimmune diseases are seen as a result of:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Doshic Imbalance<\/strong> (Lad, 2002):\n<ul class=\"wp-block-list\">\n<li><strong>Vata:<\/strong> Leads to dryness, stiffness, and irregular immune responses.<\/li>\n\n\n\n<li><strong>Pitta:<\/strong> Causes inflammation, redness, and heat in the body.<\/li>\n\n\n\n<li><strong>Kapha:<\/strong> Results in sluggishness, swelling, and accumulation of toxins.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Ama (Toxin) Build-Up<\/strong> (Frawley, 2000):\n<ul class=\"wp-block-list\">\n<li>Weak digestion and improper metabolism lead to the formation of Ama, which accumulates in tissues and triggers immune dysfunction.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Stress and Mental Imbalance<\/strong> (Gupta &amp; Keshav, 2003):\n<ul class=\"wp-block-list\">\n<li>Unmanaged stress aggravates the immune system and contributes to flare-ups.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ayurvedic-tips-for-managing-autoimmune-conditions\"><strong>Ayurvedic Tips for Managing Autoimmune Conditions<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"1-focus-on-digestive-health\"><strong>1. Focus on Digestive Health<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Poor digestion leads to toxin accumulation, which exacerbates inflammation and immune dysregulation (Mishra et al., 2001).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Eat fresh, warm, and easily digestible foods.<\/li>\n\n\n\n<li>Avoid processed, fried, and heavy foods that strain digestion.<\/li>\n\n\n\n<li>Incorporate spices like cumin, ginger, and turmeric to enhance digestion.<\/li>\n\n\n\n<li>Practice mindful eating by chewing food slowly and eating at regular intervals.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"2-detoxify-your-body\"><strong>2. Detoxify Your Body<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Cleansing the body of accumulated toxins helps reduce inflammation and restore balance (Sharma et al., 2007).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Opt for regular detoxification therapies under expert guidance.<\/li>\n\n\n\n<li>Include herbal teas made from fennel, coriander, or holy basil to support natural detoxification.<\/li>\n\n\n\n<li>Drink warm water with lemon daily to cleanse the digestive tract.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"3-balance-your-doshas\"><strong>3. Balance Your Doshas<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Addressing doshic imbalances helps reduce symptoms and restore the body\u2019s natural harmony (Lad, 2002).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>For <strong>Vata:<\/strong> Stay warm, eat grounding foods like sweet potatoes and lentils, and avoid raw or cold foods.<\/li>\n\n\n\n<li>For <strong>Pitta:<\/strong> Focus on cooling foods like cucumbers, leafy greens, and coconut water. Avoid spicy and acidic foods.<\/li>\n\n\n\n<li>For <strong>Kapha:<\/strong> Opt for light, warming foods like ginger tea, barley, and steamed vegetables. Avoid dairy and excessive sugar.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"4-strengthen-your-immunity\"><strong>4. Strengthen Your Immunity<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> A balanced immune system is crucial for reducing autoimmunity and preventing flare-ups (Singh et al., 2003).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Use personalized herbal medications to support immunity and reduce inflammation.<\/li>\n\n\n\n<li>Practice Pranayama (breathing exercises) to oxygenate cells and strengthen the immune response.<\/li>\n\n\n\n<li>Consume foods rich in antioxidants, such as fresh fruits, nuts, and seeds.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"5-manage-stress-effectively\"><strong>5. Manage Stress Effectively<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Stress is a significant trigger for autoimmune conditions, exacerbating inflammation and flare-ups (Brown &amp; Gerbarg, 2005).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Practice daily yoga and meditation to calm the mind and balance hormones.<\/li>\n\n\n\n<li>Adopt grounding practices like walking in nature or journaling.<\/li>\n\n\n\n<li>Prioritize adequate sleep by establishing a consistent bedtime routine.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"6-incorporate-anti-inflammatory-practices\"><strong>6. Incorporate Anti-Inflammatory Practices<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Reducing inflammation is key to alleviating symptoms and improving quality of life (Chainani-Wu, 2003).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Apply warm Ayurvedic oils to joints and affected areas to reduce inflammation and stiffness.<\/li>\n\n\n\n<li>Use turmeric and ginger in cooking for their potent anti-inflammatory properties.<\/li>\n\n\n\n<li>Avoid inflammatory triggers like caffeine, alcohol, and processed foods.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"7-build-a-routine-dinacharya\"><strong>7. Build a Routine (Dinacharya)<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> A structured daily routine helps regulate biological rhythms and improves overall health (Frawley, 2000).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Wake up early and perform oil pulling and tongue scraping to remove toxins.<\/li>\n\n\n\n<li>Follow regular meal times to support digestion and energy levels.<\/li>\n\n\n\n<li>Wind down with calming activities in the evening, such as reading or gentle stretching.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"8-stay-hydrated\"><strong>8. Stay Hydrated<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Proper hydration flushes out toxins and supports cellular functions (Popkin et al., 2010).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Sip warm water throughout the day to aid digestion and circulation.<\/li>\n\n\n\n<li>Avoid icy or carbonated drinks, which can disrupt digestion.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"9-regularly-monitor-your-symptoms\"><strong>9. Regularly Monitor Your Symptoms<\/strong><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why It Matters:<\/strong> Tracking symptoms helps in fine-tuning your treatment plan and identifying triggers (Sharma et al., 2007).<\/li>\n\n\n\n<li><strong>What to Do:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Maintain a journal to log dietary intake, stress levels, and symptoms.<\/li>\n\n\n\n<li>Consult your Ayurvedic practitioner regularly to review progress.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"case-study-managing-autoimmune-disease-with-ayurveda\"><strong>Case Study: Managing Autoimmune Disease with Ayurveda<\/strong><\/h3>\n\n\n\n<p><strong>Patient Profile:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Age:<\/strong> 40<\/li>\n\n\n\n<li><strong>Condition:<\/strong> Rheumatoid arthritis with joint pain, fatigue, and frequent flare-ups.<\/li>\n\n\n\n<li><strong>Triggers:<\/strong> Stress, poor digestion, and irregular lifestyle.<\/li>\n<\/ul>\n\n\n\n<p><strong>Ayurvedic Treatment Plan:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Detoxification:<\/strong> Weekly specialized external Ayurvedic therapies and herbal cleanses (Pandey &amp; Chandola, 2013).<\/li>\n\n\n\n<li><strong>Herbal Medications:<\/strong> Personalized formulations to reduce inflammation and balance Vata.<\/li>\n\n\n\n<li><strong>Dietary Adjustments:<\/strong> A Vata-pacifying diet with warming, easily digestible foods.<\/li>\n\n\n\n<li><strong>Lifestyle Changes:<\/strong> Yoga and meditation for stress management, along with regular sleep routines.<\/li>\n<\/ol>\n\n\n\n<p><strong>Outcome:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Significant reduction in joint pain and inflammation within 3 months.<\/li>\n\n\n\n<li>Improved digestion and energy levels.<\/li>\n\n\n\n<li>Flare-ups reduced by over 70% within 6 months.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"from-the-doctors-desk-key-takeaways\"><strong>From the Doctor\u2019s Desk: Key Takeaways<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Personalization is Key:<\/strong> Every autoimmune condition is unique, and treatments must be tailored to individual needs (Lad, 2002).<\/li>\n\n\n\n<li><strong>Consistency is Critical:<\/strong> Sustainable results require a commitment to diet, routine, and stress management.<\/li>\n\n\n\n<li><strong>Holistic Care is the Answer:<\/strong> Combining internal herbal medications with lifestyle changes ensures long-term remission (Sharma et al., 2007).<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"conclusion\"><strong>Conclusion<\/strong><\/h3>\n\n\n\n<p>Managing an autoimmune condition requires a holistic, patient-centered approach that addresses root causes rather than just symptoms. Ayurveda, with its emphasis on balance and natural healing, provides a comprehensive framework for achieving long-term relief and improved quality of life (Pole, 2013). At <strong>EliteAyurveda<\/strong>, we specialize in personalized treatments that empower patients to take control of their health.<\/p>\n\n\n\n<p><strong>Start your journey to wellness today.<\/strong><\/p>\n\n\n\n<p>\ud83d\udcde <strong>Contact us at +91 8884722246<\/strong><\/p>\n\n\n\n<p>\ud83c\udf10 <strong>Visit our website: <a href=\"https:\/\/www.eliteayurveda.com\/\">www.eliteayurveda.com<\/a><\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Related-<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/eliteayurveda.com\/diseases\/autoimmune\/\">Know More Ayurveda Treatments For Autoimmune Conditions.<\/a><\/p>\n\n\n\n<div class=\"wp-block-group alignfull has-text-color has-background\" style=\"color:#000000;background-color:#ffffff\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center has-small-font-size\" style=\"line-height:.9\"><strong>GET IN TOUCH<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"schedule-a-visit\" style=\"font-size:59px;line-height:1.15\"><strong><a href=\"https:\/\/www.eliteayurveda.com\/contact-us\/#\" target=\"_blank\" rel=\"noreferrer noopener\">Schedule a Visit<\/a><\/strong><\/h2>\n\n\n\n<div class=\"wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-499968f5 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-50\"><a class=\"wp-block-button__link has-text-color has-background wp-element-button\" href=\"https:\/\/www.eliteayurveda.com\/contact-us\/#\" style=\"border-radius:50px;color:#ffffff;background-color:#000000\" target=\"_blank\" rel=\"noreferrer noopener\">Contact us<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:64px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"references\"><strong>References<\/strong><\/h3>\n\n\n\n<p>1.American Autoimmune Related Diseases Association. The Cost Burden of Autoimmune Disease: The Latest Front in the War on Healthcare Spending. American Autoimmune Related Diseases Association; East Detroit, MI: 2011.\u00a0<a href=\"http:\/\/www.aarda.org\/infocus_article.php?ID=74\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/www.aarda.org\/infocus_article.php?ID=74<\/a>.\u00a0[<a href=\"https:\/\/scholar.google.com\/scholar_lookup?title=The%20Cost%20Burden%20of%20Autoimmune%20Disease:%20The%20Latest%20Front%20in%20the%20War%20on%20Healthcare%20Spending&amp;publication_year=2011&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>2.Walsh SJ, Rau LM. Autoimmune diseases: A leading cause of death among young and middle-aged women in the United States. Am J Public Health. 2000;90:1463\u20131466. doi: 10.2105\/ajph.90.9.1463.\u00a0[<a href=\"https:\/\/doi.org\/10.2105\/ajph.90.9.1463\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1447637\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10983209\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Am%20J%20Public%20Health&amp;title=Autoimmune%20diseases:%20A%20leading%20cause%20of%20death%20among%20young%20and%20middle-aged%20women%20in%20the%20United%20States&amp;author=SJ%20Walsh&amp;author=LM%20Rau&amp;volume=90&amp;publication_year=2000&amp;pages=1463-1466&amp;pmid=10983209&amp;doi=10.2105\/ajph.90.9.1463&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>3.Davis MM, Altman JD, Newell EW. Interrogating the repertoire: Broadening the scope of peptide\u2013MHC multimer analysis. Nat Rev Immunol. 2011;11:551\u2013558. doi: 10.1038\/nri3020.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/nri3020\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3699324\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21760610\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=Interrogating%20the%20repertoire:%20Broadening%20the%20scope%20of%20peptide%E2%80%93MHC%20multimer%20analysis&amp;author=MM%20Davis&amp;author=JD%20Altman&amp;author=EW%20Newell&amp;volume=11&amp;publication_year=2011&amp;pages=551-558&amp;pmid=21760610&amp;doi=10.1038\/nri3020&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>4.Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol. 2010;11:21\u201327. doi: 10.1038\/ni.1817.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/ni.1817\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20016506\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Nat%20Immunol&amp;title=Mechanisms%20maintaining%20peripheral%20tolerance&amp;author=DL%20Mueller&amp;volume=11&amp;publication_year=2010&amp;pages=21-27&amp;pmid=20016506&amp;doi=10.1038\/ni.1817&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>5.Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992;257:789\u2013792. doi: 10.1126\/science.1323143.\u00a0[<a href=\"https:\/\/doi.org\/10.1126\/science.1323143\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/1323143\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Science&amp;title=Long-term%20survival%20of%20xenogeneic%20pancreatic%20islet%20grafts%20induced%20by%20CTLA4lg&amp;author=DJ%20Lenschow&amp;author=Y%20Zeng&amp;author=JR%20Thistlethwaite&amp;author=A%20Montag&amp;author=W%20Brady&amp;volume=257&amp;publication_year=1992&amp;pages=789-792&amp;pmid=1323143&amp;doi=10.1126\/science.1323143&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>6.Maxwell LJ, Singh JA. Abatacept for rheumatoid arthritis: A Cochrane systematic review. J Rheumatol. 2010;37:234\u2013245. doi: 10.3899\/jrheum.091066.\u00a0[<a href=\"https:\/\/doi.org\/10.3899\/jrheum.091066\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20080922\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Rheumatol&amp;title=Abatacept%20for%20rheumatoid%20arthritis:%20A%20Cochrane%20systematic%20review&amp;author=LJ%20Maxwell&amp;author=JA%20Singh&amp;volume=37&amp;publication_year=2010&amp;pages=234-245&amp;pmid=20080922&amp;doi=10.3899\/jrheum.091066&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>7.Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, Wollenhaupt J, Bahary O, Becker JC, Kelly S, Sigal L, Teng J, Gladman D. Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum. 2011;63:939\u2013948. doi: 10.1002\/art.30176.\u00a0[<a href=\"https:\/\/doi.org\/10.1002\/art.30176\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21128258\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arthritis%20Rheum&amp;title=Abatacept%20in%20the%20treatment%20of%20patients%20with%20psoriatic%20arthritis:%20Results%20of%20a%20six-month,%20multicenter,%20randomized,%20double-blind,%20placebo-controlled,%20phase%20II%20trial&amp;author=P%20Mease&amp;author=MC%20Genovese&amp;author=G%20Gladstein&amp;author=AJ%20Kivitz&amp;author=C%20Ritchlin&amp;volume=63&amp;publication_year=2011&amp;pages=939-948&amp;pmid=21128258&amp;doi=10.1002\/art.30176&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>8.Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS. Type 1 Diabetes TrialNet Abatacept Study Group, Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial. Lancet. 2011;378:412\u2013419. doi: 10.1016\/S0140-6736(11)60886-6.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(11)60886-6\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3462593\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21719096\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Lancet&amp;title=Type%201%20Diabetes%20TrialNet%20Abatacept%20Study%20Group,%20Co-stimulation%20modulation%20with%20abatacept%20in%20patients%20with%20recent-onset%20type%201%20diabetes:%20A%20randomised,%20double-blind,%20placebo-controlled%20trial&amp;author=T%20Orban&amp;author=B%20Bundy&amp;author=DJ%20Becker&amp;author=LA%20DiMeglio&amp;author=SE%20Gitelman&amp;volume=378&amp;publication_year=2011&amp;pages=412-419&amp;pmid=21719096&amp;doi=10.1016\/S0140-6736(11)60886-6&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>9.Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CRG, Rusche JR, Khoury SJ. CTLA4Ig treatment in patients with multiple sclerosis: An open-label, phase 1 clinical trial. Neurology. 2008;71:917\u2013924. doi: 10.1212\/01.wnl.0000325915.00112.61.\u00a0[<a href=\"https:\/\/doi.org\/10.1212\/01.wnl.0000325915.00112.61\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18794494\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Neurology&amp;title=CTLA4Ig%20treatment%20in%20patients%20with%20multiple%20sclerosis:%20An%20open-label,%20phase%201%20clinical%20trial&amp;author=V%20Viglietta&amp;author=K%20Bourcier&amp;author=GJ%20Buckle&amp;author=B%20Healy&amp;author=HL%20Weiner&amp;volume=71&amp;publication_year=2008&amp;pages=917-924&amp;pmid=18794494&amp;doi=10.1212\/01.wnl.0000325915.00112.61&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>10.Merrill JT, Burgos-Vargas R, Westhovens R, Chalmers A, D\u2019Cruz D, Wallace DJ, Bae SC, Sigal L, Becker JC, Kelly S, Raghupathi K, Li T, Peng Y, Kinaszczuk M, Nash P. The efficacy and safety of abatacept in patients with non\u2013life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62:3077\u20133087. doi: 10.1002\/art.27601.\u00a0[<a href=\"https:\/\/doi.org\/10.1002\/art.27601\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20533545\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Arthritis%20Rheum&amp;title=The%20efficacy%20and%20safety%20of%20abatacept%20in%20patients%20with%20non%E2%80%93life-threatening%20manifestations%20of%20systemic%20lupus%20erythematosus:%20Results%20of%20a%20twelve-month,%20multicenter,%20exploratory,%20phase%20IIb,%20randomized,%20double-blind,%20placebo-controlled%20trial&amp;author=JT%20Merrill&amp;author=R%20Burgos-Vargas&amp;author=R%20Westhovens&amp;author=A%20Chalmers&amp;author=D%20D%E2%80%99Cruz&amp;volume=62&amp;publication_year=2010&amp;pages=3077-3087&amp;pmid=20533545&amp;doi=10.1002\/art.27601&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>11.Felix NJ, Suri A, Salter-Cid L, Nadler SG, Gujrathi S, Corbo M, Aranda R. Targeting lymphocyte co-stimulation: From bench to bedside. Autoimmunity. 2010;43:514\u2013525. doi: 10.3109\/08916931003674741.\u00a0[<a href=\"https:\/\/doi.org\/10.3109\/08916931003674741\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20429850\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Autoimmunity&amp;title=Targeting%20lymphocyte%20co-stimulation:%20From%20bench%20to%20bedside&amp;author=NJ%20Felix&amp;author=A%20Suri&amp;author=L%20Salter-Cid&amp;author=SG%20Nadler&amp;author=S%20Gujrathi&amp;volume=43&amp;publication_year=2010&amp;pages=514-525&amp;pmid=20429850&amp;doi=10.3109\/08916931003674741&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>12.Salomon B, Bluestone JA. Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225\u2013252. doi: 10.1146\/annurev.immunol.19.1.225.\u00a0[<a href=\"https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.225\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11244036\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Annu%20Rev%20Immunol&amp;title=Complexities%20of%20CD28\/B7:%20CTLA-4%20costimulatory%20pathways%20in%20autoimmunity%20and%20transplantation&amp;author=B%20Salomon&amp;author=JA%20Bluestone&amp;volume=19&amp;publication_year=2001&amp;pages=225-252&amp;pmid=11244036&amp;doi=10.1146\/annurev.immunol.19.1.225&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>13.Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490\u2013500. doi: 10.1038\/nri2785.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/nri2785\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20559327\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=FOXP3+%20regulatory%20T%20cells%20in%20the%20human%20immune%20system&amp;author=S%20Sakaguchi&amp;author=M%20Miyara&amp;author=CM%20Costantino&amp;author=DA%20Hafler&amp;volume=10&amp;publication_year=2010&amp;pages=490-500&amp;pmid=20559327&amp;doi=10.1038\/nri2785&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>14.Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057\u20131061. doi: 10.1126\/science.1079490.\u00a0[<a href=\"https:\/\/doi.org\/10.1126\/science.1079490\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12522256\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Science&amp;title=Control%20of%20regulatory%20T%20cell%20development%20by%20the%20transcription%20factor%20Foxp3&amp;author=S%20Hori&amp;author=T%20Nomura&amp;author=S%20Sakaguchi&amp;volume=299&amp;publication_year=2003&amp;pages=1057-1061&amp;pmid=12522256&amp;doi=10.1126\/science.1079490&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>15.Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6:270\u2013277. doi: 10.1038\/nrendo.2010.40.\u00a0[<a href=\"https:\/\/doi.org\/10.1038\/nrendo.2010.40\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20309000\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Nat%20Rev%20Endocrinol&amp;title=Autoimmune%20polyglandular%20syndromes&amp;author=AW%20Michels&amp;author=PA%20Gottlieb&amp;volume=6&amp;publication_year=2010&amp;pages=270-277&amp;pmid=20309000&amp;doi=10.1038\/nrendo.2010.40&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>16.Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28\u201350. doi: 10.1111\/j.0105-2896.2006.00420.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.0105-2896.2006.00420.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16903904\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Immunol%20Rev&amp;title=Interleukin-10-secreting%20type%201%20regulatory%20T%20cells%20in%20rodents%20and%20humans&amp;author=MG%20Roncarolo&amp;author=S%20Gregori&amp;author=M%20Battaglia&amp;author=R%20Bacchetta&amp;author=K%20Fleischhauer&amp;volume=212&amp;publication_year=2006&amp;pages=28-50&amp;pmid=16903904&amp;doi=10.1111\/j.0105-2896.2006.00420.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>17.Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat auto-immunity. Immunol Rev. 2006;212:217\u2013237. doi: 10.1111\/j.0105-2896.2006.00421.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.0105-2896.2006.00421.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16903917\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Immunol%20Rev&amp;title=Regulatory%20T-cell%20physiology%20and%20application%20to%20treat%20auto-immunity&amp;author=Q%20Tang&amp;author=JA%20Bluestone&amp;volume=212&amp;publication_year=2006&amp;pages=217-237&amp;pmid=16903917&amp;doi=10.1111\/j.0105-2896.2006.00421.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>18.Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells. Trends Immunol. 2006;27:541\u2013544. doi: 10.1016\/j.it.2006.10.002.\u00a0[<a href=\"https:\/\/doi.org\/10.1016\/j.it.2006.10.002\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17045841\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Trends%20Immunol&amp;title=Cell-surface%20IL-7%20receptor%20expression%20facilitates%20the%20purification%20of%20FOXP3+%20regulatory%20T%20cells&amp;author=AH%20Banham&amp;volume=27&amp;publication_year=2006&amp;pages=541-544&amp;pmid=17045841&amp;doi=10.1016\/j.it.2006.10.002&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>19.Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, Shevach EM. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I\/II (CD121a\/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood. 2009;113:5125\u20135133. doi: 10.1182\/blood-2009-01-199950.\u00a0[<a href=\"https:\/\/doi.org\/10.1182\/blood-2009-01-199950\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2686183\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19299332\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Blood&amp;title=Selective%20expression%20of%20latency-associated%20peptide%20(LAP)%20and%20IL-1%20receptor%20type%20I\/II%20(CD121a\/CD121b)%20on%20activated%20human%20FOXP3+%20regulatory%20T%20cells%20allows%20for%20their%20purification%20from%20expansion%20cultures&amp;author=DQ%20Tran&amp;author=J%20Andersson&amp;author=D%20Hardwick&amp;author=L%20Bebris&amp;author=GG%20Illei&amp;volume=113&amp;publication_year=2009&amp;pages=5125-5133&amp;pmid=19299332&amp;doi=10.1182\/blood-2009-01-199950&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>20.Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK. CD4+ T-regulatory cells: Toward therapy for human diseases. Immunol Rev. 2008;223:391\u2013421. doi: 10.1111\/j.1600-065X.2008.00634.x.\u00a0[<a href=\"https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00634.x\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18613849\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Immunol%20Rev&amp;title=CD4+%20T-regulatory%20cells:%20Toward%20therapy%20for%20human%20diseases&amp;author=SE%20Allan&amp;author=R%20Broady&amp;author=S%20Gregori&amp;author=ME%20Himmel&amp;author=N%20Locke&amp;volume=223&amp;publication_year=2008&amp;pages=391-421&amp;pmid=18613849&amp;doi=10.1111\/j.1600-065X.2008.00634.x&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>21.Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, McKenna DH, Bromberg JS, Levine BL, Riley JL, June CH, Scheinberg P, Douek DC, Miller JS, Wagner JE, Blazar BR. Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity. Sci Transl Med. 2011;3:83ra41. doi: 10.1126\/scitranslmed.3001809.\u00a0[<a href=\"https:\/\/doi.org\/10.1126\/scitranslmed.3001809\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3551476\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21593401\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=Massive%20ex%20vivo%20expansion%20of%20human%20natural%20regulatory%20T%20cells%20(Tregs)%20with%20minimal%20loss%20of%20in%20vivo%20functional%20activity&amp;author=KL%20Hippen&amp;author=SC%20Merkel&amp;author=DK%20Schirm&amp;author=CM%20Sieben&amp;author=D%20Sumstad&amp;volume=3&amp;publication_year=2011&amp;pages=83ra41&amp;pmid=21593401&amp;doi=10.1126\/scitranslmed.3001809&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>22.Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 2009;58:652\u2013662. doi: 10.2337\/db08-1168.\u00a0[<a href=\"https:\/\/doi.org\/10.2337\/db08-1168\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2646064\/\" target=\"_blank\" rel=\"noopener\">PMC free article<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19074986\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=Diabetes&amp;title=Expansion%20of%20human%20regulatory%20T-cells%20from%20patients%20with%20type%201%20diabetes&amp;author=AL%20Putnam&amp;author=TM%20Brusko&amp;author=MR%20Lee&amp;author=W%20Liu&amp;author=GL%20Szot&amp;volume=58&amp;publication_year=2009&amp;pages=652-662&amp;pmid=19074986&amp;doi=10.2337\/db08-1168&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n\n\n\n<p>23.Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L, Wang Y, Ayyoub M. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol. 2006;177:944\u2013949. doi: 10.4049\/jimmunol.177.2.944.\u00a0[<a href=\"https:\/\/doi.org\/10.4049\/jimmunol.177.2.944\" target=\"_blank\" rel=\"noreferrer noopener\">DOI<\/a>] [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16818749\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a>] [<a href=\"https:\/\/scholar.google.com\/scholar_lookup?journal=J%20Immunol&amp;title=Rapamycin-mediated%20enrichment%20of%20T%20cells%20with%20regulatory%20activity%20in%20stimulated%20CD4+%20T%20cell%20cultures%20is%20not%20due%20to%20the%20selective%20expansion%20of%20naturally%20occurring%20regulatory%20T%20cells%20but%20to%20the%20induction%20of%20regulatory%20functions%20in%20conventional%20CD4+%20T%20cells&amp;author=D%20Valmori&amp;author=V%20Tosello&amp;author=NE%20Souleimanian&amp;author=E%20Godefroy&amp;author=L%20Scotto&amp;volume=177&amp;publication_year=2006&amp;pages=944-949&amp;pmid=16818749&amp;doi=10.4049\/jimmunol.177.2.944&amp;\" target=\"_blank\" rel=\"noreferrer noopener\">Google Scholar<\/a>]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ayurvedic Tips for Managing Your Autoimmune Condition Introduction Autoimmune conditions, where the immune system mistakenly attacks the body\u2019s healthy tissues, can lead to chronic inflammation and a range of symptoms affecting various organs and systems (Davidson &amp; Diamond, 2001). Conditions like rheumatoid arthritis, lupus, multiple sclerosis, and psoriasis are examples of autoimmune disorders that often [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5083,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-3391","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-general"},"_links":{"self":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/comments?post=3391"}],"version-history":[{"count":2,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3391\/revisions"}],"predecessor-version":[{"id":5084,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/posts\/3391\/revisions\/5084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media\/5083"}],"wp:attachment":[{"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/media?parent=3391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/categories?post=3391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eliteayurveda.com\/blog\/wp-json\/wp\/v2\/tags?post=3391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}